Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Pfizer
(NYSE:PFE)
Intraday
$28.775
0.395
[1.39%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$28.775
0.395
[1.39%]
Last update: 3:10PM
Get Real Time Here
Get Report
Watch
The dividend Ex-Date was 6 days ago
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Pfizer Stock (NYSE:PFE)
Pfizer Stock (NYSE: PFE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, May 15, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
-
1 hour ago
Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals And A Major Tech Stock On CNBC's 'Final Trades'
Avi Kapoor
-
6 hours ago
Tuesday, May 14, 2024
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
Nicolás Jose Rodriguez
-
1 day ago
CNBC Halftime Report Final Trades: Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals, QUALCOMM
Benzinga Newsdesk
-
1 day ago
Monday, May 13, 2024
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Vandana Singh
-
2 days ago
Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France's Healthcare Sector
Vandana Singh
-
2 days ago
ViiV Healthcare Says Health Canada Approved APRETUDE For Pre-Exposure Prophylaxis To Reduce Risk Of Sexually Acquired HIV
Benzinga Newsdesk
-
2 days ago
'Seems Low:' Elon Musk Questions Pfizer's $0 Tax Bill, But Did Tesla Pony Up To Uncle Sam?
Shanthi Rexaline
-
2 days ago
Friday, May 10, 2024
Stocks Surge On Healthy Earnings Season, Rising Jobless Claims: This Week In The Markets
Piero Cingari
-
4 days ago
FDA Delays 'Important' Moderna Vaccine Review: William Blair Says 2025 Growth, '2026 Breakeven Story' Depends On It
Vandana Singh
-
5 days ago
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields
Avi Kapoor
-
5 days ago
Thursday, May 09, 2024
Spotlight on Pfizer: Analyzing the Surge in Options Activity
Benzinga Insights
-
5 days ago
A Look at Pharma ETFs Post Q1 Earnings
Zacks
-
6 days ago
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Shanthi Rexaline
-
6 days ago
Wednesday, May 08, 2024
Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With Discontinued Heartburn Drug Zantac
Vandana Singh
-
May 8, 2024, 2:58PM
Second Death - Pfizer Reports Young Boy's Death After One Year Of Gene Therapy Treatment In Muscle Wasting Disorder Trial
Vandana Singh
-
May 8, 2024, 1:09PM
Jim Cramer Advises Investors To Brace For Economic Slowdown, Shares Tips To Maintain Balanced Portfolio: 'I'm Not Telling You To Relax'
Benzinga Neuro
-
May 8, 2024, 2:26AM
Tuesday, May 07, 2024
Sarepta Therapeutics Shares Move Higher; Traders Circulate STAT News Report 'Young boy dies in trial for Pfizer Duchenne gene therapy.' BZ NOTE: Co Makes Competing DMD Drug
Benzinga Newsdesk
-
May 7, 2024, 3:52PM
Watching Pfizer Shares; Traders Circulating STAT News Report 'Young boy dies in trial for Pfizer Duchenne gene therapy'
Benzinga Newsdesk
-
May 7, 2024, 3:31PM
Monday, May 06, 2024
Pfizer's Options Frenzy: What You Need to Know
Benzinga Insights
-
May 6, 2024, 4:45PM
What's Going With BioNTech Stock On Monday?
Vandana Singh
-
May 6, 2024, 10:02AM
Friday, May 03, 2024
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks
-
May 3, 2024, 4:00PM
Thursday, May 02, 2024
Pfizer Prospects Garner Mixed Sentiment From Analysts: 'Finally, The Pivot Investors Have Been Waiting For'
Vandana Singh
-
May 2, 2024, 3:15PM
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
-
May 2, 2024, 1:35PM
Morgan Stanley Maintains Equal-Weight on Pfizer, Raises Price Target to $29
Benzinga Newsdesk
-
May 2, 2024, 1:12PM
Pfizer shares are trading higher on continued strength after the company, on Wednesday, reported better-than-expected Q1 financial results. Josh Brown, on CNBC, made a bullish call on the stock.
Benzinga Newsdesk
-
May 2, 2024, 12:42PM
Live On CNBC, Josh Brown Announces He Has "Doubled Down On Pfizer"
Benzinga Newsdesk
-
May 2, 2024, 12:22PM
BMO Capital Reiterates Outperform on Pfizer, Raises Price Target to $36
Benzinga Newsdesk
-
May 2, 2024, 10:27AM
Pfizer Unusual Options Activity
Benzinga Insights
-
May 2, 2024, 9:46AM
Investor Optimism Improves Slightly Following Fed Decision
Avi Kapoor
-
May 2, 2024, 2:37AM
Wednesday, May 01, 2024
Carvana, Enovix, Pfizer, Nio, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Benzinga Neuro
-
May 1, 2024, 10:52PM
Dow Jumps 200 Points Following Fed Decision; Pfizer Earnings Top Estimates
Avi Kapoor
-
May 1, 2024, 2:32PM
US Stocks Mixed Ahead Of Fed Meeting, Chipmakers Tumble After AMD Earnings, Bitcoin Sinks: What's Driving Markets Wednesday?
Piero Cingari
-
May 1, 2024, 1:07PM
Pfizer Exec Says Co Is Progressing On Retail Contracting For RSV Vaccine; RSV Vaccine Performance Was In Line With Expectations In QTR; Patent Term Extension, If Granted, Could Extend U.S. Exclusivity For Heart Disease Drug Vyndamax To Dec 2028
Benzinga Newsdesk
-
May 1, 2024, 10:54AM
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To Perform Consistently With Expectations
Vandana Singh
-
May 1, 2024, 10:38AM
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Vandana Singh
-
May 1, 2024, 9:42AM
Pfizer Sees FY24 Revenues $58.5B-$61.5B Vs $62.92B Estimate
Benzinga Newsdesk
-
May 1, 2024, 6:50AM
Pfizer Sees FY24 Adj. EPS $2.15-$2.35 Vs $2.76 Estimate
Benzinga Newsdesk
-
May 1, 2024, 6:49AM
Pfizer shares are trading higher after the company reported better-than-expected Q1 financial results.
Benzinga Newsdesk
-
May 1, 2024, 6:46AM
Pfizer Q1 2024 Adj EPS $0.82 Beats $0.54 Estimate, Sales $14.90B Beat $14.20B Estimate
Benzinga Newsdesk
-
May 1, 2024, 6:46AM
FT Earlier Reported Pfizer To Sell Covid And Migraine Drugs Directly To Consumers
Benzinga Newsdesk
-
May 1, 2024, 6:44AM
Wall Street Set To Open Lower After AMD Earnings Disappoint As Traders Look To Fed's Powell For Relief: Why This Analyst Sees Incoming Summer Rally
Shanthi Rexaline
-
May 1, 2024, 6:44AM
Investor Sentiment Falls, Dow Snaps Five-Month Win Streak
Avi Kapoor
-
May 1, 2024, 3:42AM
Amazon, Pfizer And 3 Stocks To Watch Heading Into Wednesday
Avi Kapoor
-
May 1, 2024, 3:42AM
Tuesday, April 30, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
-
Apr 30, 2024, 1:35PM
Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings
Surbhi Jain
-
Apr 30, 2024, 11:18AM
(PFE) - Analyzing Pfizer's Short Interest
Benzinga Insights
-
Apr 30, 2024, 10:45AM
Monday, April 29, 2024
FDA OKs Seagen's Tivdak (tisotumab vedotin-tftv) For Cervical Cancer
Benzinga Newsdesk
-
Apr 29, 2024, 3:53PM
What Makes Amazon Attractive Ahead of Q1 Earnings?
Zacks
-
Apr 29, 2024, 12:11PM
mRNA Is Promising A Breakthrough In Fighting Cancer
Upwallstreet
-
Apr 29, 2024, 10:02AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch